Turning Complexity into Clarity in Advanced Cervical Cancer: Tapping into the Power of Collaborative Peer-focused Education
Presented by: Johns Hopkins School of Medicine
Estimated time to complete this activity: 4 hours and 25 minutes. This activity has been approved for a maximum of 4.25 AMA PRA Category 1 Credits™.
Fees and Prerequisites: There are no fees or prerequisites.
Acknowledgement of Commercial Support: Supported by an independent educational grant from Regeneron
This activity is intended to meet the educational needs of healthcare professionals involved in the care of patients with cervical cancer.
After participating in this activity, learners will demonstrate the ability to:
The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation Statement
The Johns Hopkins University School of Medicine designates this enduring material for a maximum of 4.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Nurses Credentialing Center (ANCC) accepts AMA PRA Category 1 CreditTM from organizations accredited by the ACCME.
American Association of Nurse Practitioners National Certification Program accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.
American Academy of PAs (AAPA) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. PAs may receive a maximum of 4.25 AAPA Category 1 Credit for completing this program.
Statement of Need
The current treatment of advanced, recurrent, and metastatic cervical cancer is difficult, especially as treatment progresses to the second line. Considerations for treatment are nuanced and numerous. Factors include prior treatments, treatment timing, and patient preference. The advent of targeted therapies has brought improved outcomes for those patients whose tumors harbor specific mutations. Still for those who are ineligible for targeted therapies, currently available options are lacking. Agents in the pipeline of development and potential approval offer hope for the treatment of this difficult to manage disease. This collaborative social learning platform establishes a network of providers who can support each other locally, as well as those from different communities, with the goal of learning and sharing best practices that will improve outcomes for patients with cervical cancer.
Johns Hopkins Faculty:
Stéphanie Gaillard, MD, PhD
Assistant Professor, Oncology and Gynecology/Obstetrics
Director of Gynecologic Cancer Trials
Director of Developmental Therapeutics
Johns Hopkins Hospital
Kimberly Levinson, MD, MPH
Associate Professor of Gynecology and Obstetrics
Director of the Johns Hopkins Gynecologic Oncology Program at the Greater Baltimore Medical Center
Johns Hopkins University
Policy on Speaker and Provider Disclosure
It is the policy of the Johns Hopkins University School of Medicine that the speaker and provider globally disclose conflicts of interest. The Johns Hopkins University School of Medicine OCME has established policies in place that will identify and resolve conflicts of interest prior to this educational activity. Detailed disclosure will be made prior to presentation of the education.
Johns Hopkins Statement of Responsibility
The Johns Hopkins School of Medicine takes responsibility for the content, quality, and scientific integrity of this CME activity.
Internet CME Policy
The Office of Continuing Medical Education (OCME) at the Johns Hopkins School of Medicine is committed to protecting the privacy of its members and customers. Johns Hopkins School of Medicine OCME maintains its Internet site as an information resource and service for physicians, other health professionals and the public. OCME at the Johns Hopkins School of Medicine will keep your personal and credit information confidential when you participate in a CME Internet based program. Your information will never be given to anyone outside of the Johns Hopkins School of Medicine CME program. CME collects only the information necessary to provide you with the services that you request.
All rights reserved - The Johns Hopkins School of Medicine. No part of this program may be used or reproduced in any manner whatsoever without written permission except in the case of brief quotations embodied in articles or reviews.
Format and Method of Participation
Review this internet-based CME activity. To take the post-test, please click on the post-test button below the video window of the player which will take you to the Johns Hopkins School of Medicine’s website. If you already have registered for other programs at this website, simply enter the requested information when prompted. Otherwise, complete the registration form to begin the testing process. The information you enter here will be used to generate your CME certificate. Please complete all fields to ensure accurate registration. Complete the post-test and evaluation and attest to the amount of time spent in the activity. Upon receiving a score of 70% or above, print your CME certificate.
Full Disclosure Policy Affecting CME Activities
As a provider approved by the Accreditation Council for Continuing Medical Education (ACCME), Johns Hopkins School of Medicine Office of Continuing Medical Education (OCME) requires attested and signed global disclosure of the existence of all financial interests or relationships with commercial interest from any individual in a position to control the content of a CME activity sponsored by OCME. The following relationships have been reported for this activity:
Stéphanie Gaillard, MD, PhD – Advisor: Arcus, AstraZeneca, Elevar Therapeutics, GSK Diagnostics, Novartis AG, Rigel, Sermonix; Grant or Research Support: AstraZeneca, Genentech, Inc., GlaxoSmithKline, Iovance, Pharmamar; Royalties or Patent Beneficiary: Sermonix
Kimberly Levinson, MD, MPH – No relevant financial relationships to disclose
Note: Grants to investigators at The Johns Hopkins University are negotiated and administered by the institution which receives the grants, typically through the Office of Research Administration. Individual investigators who participate in the sponsored project(s) are not directly compensated by the sponsor, but may receive salary or other support from the institution to support their effort on the project(s).
There are no references to off-label/unapproved uses of products in this program.
The opinions and recommendations expressed by faculty and other experts, whose input is included in this program are their own. This enduring material is produced for educational purposes only. Use of the Johns Hopkins School of Medicine name implies review of educational format design and approach. Please review the complete prescribing information of specific drugs or combinations of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.
Privacy Statement/Internet Policy
The Office of Continuing Medical Education (CME) at the Johns Hopkins University School of Medicine is committed to protecting the privacy of its members and customers. The Johns Hopkins School of Medicine CME maintains its Internet site as an information resource and service for physicians, other health professionals and the public. Continuing Medical Education at the Johns Hopkins School of Medicine will keep your personal and credit information confidential when you participate in a CME Internet-based program. Your information will never be given to anyone outside of the Johns Hopkins School of Medicine's CME program. Continuing Medical Education collects only the information necessary to provide you with the services that you request.
AMERICANS WITH DISABILITIES ACT
The Johns Hopkins School of Medicine fully complies with the legal requirements of the ADA and the rules and regulations thereof. Please notify us if you have any special needs.